What is the ticker symbol for MannKind?

MannKind trades under the ticker MNKD on NASDAQ.

What sector does MannKind operate in?

MannKind is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MNKD in a portfolio?

PortView shows MNKD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

MannKind (MNKD) Stock Analysis

NASDAQHealthcareBiotechnology

$4.03+1.13%

1-year price historyRange $2.28 – $6.21

52-week range$4.03

$2.23$6.51

What MannKind does

MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.

Key metrics

Market cap

$1.29B

P/E (TTM)

-30.96

EPS (TTM)

$-0.13

Beta

1.10

Dividend yield

0.00%

Revenue / share

$1.27

50-day avg

$4.03

200-day avg

$4.17

52-week high

$6.51

52-week low

$2.23

CEO

Michael E. Castagna

ETFs linked to MNKD

Broad-market and Healthcare sector ETFs an investor holding MannKind is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MNKD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MNKD in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for MannKind?: MannKind trades under the ticker MNKD on NASDAQ.
Which exchange is MNKD listed on?: MNKD is listed on NASDAQ.
What sector does MannKind operate in?: MannKind is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MNKD in a portfolio?: PortView shows MNKD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.